Evidence map›Paper›PMID 42263604›Full record

ArticleBiochemical and biophysical research communications2026

In vitro cleavage requirements and specificities of mycobacterial RNase E.

Abigail R Rapiejko, Manchi Reddy, James C Sacchettini, Scarlet S Shell

Abstract read
In one paragraph

Article in Biochemical and biophysical research communications, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Abigail R RapiejkoDepartment of Biology & Biotechnology, Worcester Polytechnic Institute, United States.
Manchi ReddyDepartment of Biochemistry & Biophysics, Texas A&M University, United States.
James C SacchettiniDepartment of Biochemistry & Biophysics, Texas A&M University, United States.
Scarlet S ShellDepartment of Biology & Biotechnology, Worcester Polytechnic Institute, United States. Electronic address: sshell@wpi.edu.

Funding

Surviving evolution: Short-term adaptations for fitnessP01AI143575 · NIAID · WEILL MEDICAL COLL OF CORNELL UNIV · PI SABINE EHRT · 2020 to 2026
$18.2M
The roles of sRNA in the physiology and pathogenesis of Mycobacterium abscessus and other mycobacteriaR21AI156415 · NIAID · WORCESTER POLYTECHNIC INSTITUTE · PI SHELL, SCARLET SARA · 2021 to 2022
$395k
NIAID NIH HHS P01 AI143575NIAID NIH HHS R21 AI156415
6 · The paper itself

Abstract

Regulation of RNA pools allows for adaptation to stress, which is important in pathogenic bacteria such as Mycobacterium tuberculosis (Mtb). RNA degradation is a significant contributor to RNA abundance, and Ribonuclease (RNase) E has a rate-limiting role in degradation of most mycobacterial transcripts. Many open questions remain about the RNA substrate requirements and specificities for efficient cleavage by mycobacterial RNase E. Here, we demonstrate that RNase E is only active on substrates with a minimum length of approximately 27 nt using both Mtb and Mycolicibacterium smegmatis (Msm) enzyme variants. Furthermore, we show that mycobacterial RNase E prefers substrates with 5' monophosphates to 5' triphosphates. We present that the positions of cleavage events by RNase E within substrates are dictated by both sequence and distance from the RNA ends. Finally, we show that Msm RNase E behaves similarly to Mtb RNase E, validating the use of this model organism for RNA degradation studies.

Indexed as

EndoribonucleasesMycobacterium smegmatisMycobacterium tuberculosisRNA, BacterialBase SequenceRNA StabilitySubstrate SpecificityEndoribonucleasesribonuclease ERNA, BacterialCleavage specificityRNA degradationRNase E

Identifiers

PMID42263604
PMCPMC13633751

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.